HADD SCIENCE

🧬 Advanced bio company HADD Science enters cosmeceuticals and regenerative medicine at once!

Card News. Learn more about HADD Science. @haddscience
chapter 01. 🧬 Advanced Bio-company 'HADD Science', Launches into Cosmeceuticals and Regenerative Medicine Simultaneously!
chapter 01. 👉Beyond research cell culture materials, we introduce HADD Science's new challenge in human application validation for wound healing and skin regeneration.. 2026 Medibio Core Material Validation Test Officially Begins!
chapter 02. Beyond wound healing to 'nerve regeneration' 🌍. The core technology utilizes naturally derived DNA (polynucleotide) based materials to induce 'Electrotaxis' in cells. While accelerating wound healing in burn and wound patients, it also promotes the regeneration of sensory and autonomic nerve fibers in the skin's superficial layer.
chapter 03. Validation of Flagship Product 'ADDGEL' and Next-Gen Wound Treatment 'NeuroHeal' 🧫. Operetta CLS High-Content Analysis System The PhenoCycler-Fusion 2.0 Solution (formerly CODEX)
chapter 03. In collaboration with the Gyeonggi Economic Science Institute, we are verifying the efficacy of our flagship portfolio, ADDGEL and NeuroHeal. Advanced imaging analysis equipment will rapidly analyze the expression of neuronal biomarkers (Tuj1, PGP9.5, etc.), with plans to expand indications to diabetic foot ulcers and chemotherapy-induced peripheral neuropathy (CIPN) treatment.
chapter 04. Gel-type Skin Booster 'BioCharge' 🔬. With support from Daegu Technopark, we are conducting primary human skin irritation tests for 2 types for general skin and 1 type for sensitive skin. We are securing credible safety data to ensure advanced bio-materials are trusted by dermatology and aesthetic professionals. 🎉
chapter 05. Perfect Commercialization Preparation through Expert Collaboration 💻. For successful market entry, we are conducting 20 hours of external expert technical guidance. This includes optimizing formulation stability and ingredient blending, establishing influencer marketing strategies based on target customers, and systematically reviewing complex clinical trial design consultations. 🧬
chapter 06. Proving K-Bio's Competitiveness with Global Exports ✨
chapter 06. The data secured through this validation test will serve as evidence to replace expensive imported dermocosmetic products. Furthermore, we will proactively respond to medical device (Class II wound dressing) approval and global regulatory requirements (US MoCRA, EU CPNP, CE/FDA) to accelerate HADD Science's overseas expansion. 🧬
chapter 07. R&D to REGENERATION. 2026 Medibio Validation Test Begins
Back to list